Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P B Laub

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Journal of the National Cancer Institute|December 18, 1996
Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomiesH Salazar, A K Godwin, M B Daly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 1996
Phase I trial of the thymidylate synthase inhibitor AG331 as a 5-day continuous infusionP J O'Dwyer, P B Laub, D DeMaria, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Journal of the National Cancer Institute|December 18, 1996
Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomiesH Salazar, A K Godwin, M B Daly, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 1, 1996
Phase I trial of the thymidylate synthase inhibitor AG331 as a 5-day continuous infusionP J O'Dwyer, P B Laub, D DeMaria, et al.
Pageof 2